Myriam Witvrouw

10.0k total citations
192 papers, 8.1k citations indexed

About

Myriam Witvrouw is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, Myriam Witvrouw has authored 192 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Infectious Diseases, 120 papers in Virology and 61 papers in Organic Chemistry. Recurrent topics in Myriam Witvrouw's work include HIV/AIDS drug development and treatment (155 papers), HIV Research and Treatment (120 papers) and Biochemical and Molecular Research (27 papers). Myriam Witvrouw is often cited by papers focused on HIV/AIDS drug development and treatment (155 papers), HIV Research and Treatment (120 papers) and Biochemical and Molecular Research (27 papers). Myriam Witvrouw collaborates with scholars based in Belgium, France and United States. Myriam Witvrouw's co-authors include Erik De Clercq, Christophe Pannecouque, Zeger Debyser, Jan Balzarini, Jan Desmyter, Dominique Schols, Robert Snoeck, Graciela Andreï, Frauke Christ and Rudi Pauwels and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Myriam Witvrouw

191 papers receiving 7.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Myriam Witvrouw Belgium	53	3.4k	3.1k	2.7k	2.6k	974	192	8.1k
Robert W. Buckheit United States	47	3.0k 0.9×	2.9k 0.9×	2.1k 0.8×	3.0k 1.1×	1.1k 1.1×	190	8.2k
James B. McMahon United States	55	1.7k 0.5×	1.8k 0.6×	2.5k 0.9×	4.4k 1.7×	819 0.8×	177	9.5k
Shirô Shigeta Japan	46	2.2k 0.7×	1.3k 0.4×	1.1k 0.4×	1.8k 0.7×	2.3k 2.3×	218	6.4k
Graciela Andreï Belgium	58	3.0k 0.9×	1.6k 0.5×	4.6k 1.7×	4.1k 1.6×	4.7k 4.8×	509	13.0k
Jan Balzarini Belgium	46	2.2k 0.6×	1.2k 0.4×	2.7k 1.0×	3.8k 1.5×	1.4k 1.4×	213	7.6k
Rudi Pauwels Belgium	63	9.2k 2.7×	8.1k 2.6×	2.8k 1.0×	4.4k 1.7×	3.4k 3.5×	145	14.9k
Barry R. O’Keefe United States	43	917 0.3×	1.1k 0.4×	1.4k 0.5×	3.5k 1.3×	762 0.8×	157	6.1k
Christophe Pannecouque Belgium	64	7.0k 2.1×	5.0k 1.6×	8.8k 3.2×	4.9k 1.9×	2.8k 2.9×	587	17.2k
Masanori Baba Japan	62	6.9k 2.1×	5.9k 1.9×	3.6k 1.3×	5.0k 1.9×	3.3k 3.4×	372	16.0k
Jim A. Turpin United States	36	1.5k 0.4×	1.9k 0.6×	730 0.3×	1.4k 0.6×	617 0.6×	91	4.3k

Countries citing papers authored by Myriam Witvrouw

Since Specialization

Citations

This map shows the geographic impact of Myriam Witvrouw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myriam Witvrouw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myriam Witvrouw more than expected).

Fields of papers citing papers by Myriam Witvrouw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myriam Witvrouw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myriam Witvrouw. The network helps show where Myriam Witvrouw may publish in the future.

Co-authorship network of co-authors of Myriam Witvrouw

This figure shows the co-authorship network connecting the top 25 collaborators of Myriam Witvrouw. A scholar is included among the top collaborators of Myriam Witvrouw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myriam Witvrouw. Myriam Witvrouw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bethell, Richard C., Joseph Schérer, Myriam Witvrouw, et al.. (2011). Short Communication: Phenotypic Protease Inhibitor Resistance and Cross-Resistance in the Clinic from 2006 to 2008 and Mutational Prevalences in HIV from Patients with Discordant Tipranavir and Darunavir Susceptibility Phenotypes. AIDS Research and Human Retroviruses. 28(9). 1019–1024. 7 indexed citations

Lion, Cédric, Fabrice Bailly, Nadia Touati, et al.. (2010). New 2-arylnaphthalenediols and triol inhibitors of HIV-1 integrase—Discovery of a new polyhydroxylated antiviral agent. Bioorganic & Medicinal Chemistry. 18(14). 5194–5201. 10 indexed citations

Hombrouck, Anneleen, Barbara Van Remoortel, Martine Michiels, et al.. (2008). Preclinical Evaluation of 1H-Benzylindole Derivatives as Novel Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors. Antimicrobial Agents and Chemotherapy. 52(8). 2861–2869. 17 indexed citations

Selvam, Parasuraman, et al.. (2008). Design, synthesis and antiHIV activity of novel isatine-sulphonamides. Indian Journal of Pharmaceutical Sciences. 70(6). 779–779. 33 indexed citations

Witvrouw, Myriam, Christophe Pannecouque, William M. Switzer, et al.. (2004). Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: Implications for treatment and postexposure prophylaxis. Antiviral Research. 62(2). 1 indexed citations

Witvrouw, Myriam, Valery Fikkert, Bénédicte Van Maele, et al.. (2002). Antiviral resistance to diketo acids is associated with the mutations T66I, L74M and S230R in the HIV-1 integrase gene. Antiviral Research. 53(3). 1 indexed citations

Kolocouris, Antonios, Kostas Dimas, Christophe Pannecouque, et al.. (2002). New 2-(1-adamantylcarbonyl)pyridine and 1-acetyladamantane thiosemicarbazones–thiocarbonohydrazones: cell growth inhibitory, antiviral and antimicrobial activity evaluation. Bioorganic & Medicinal Chemistry Letters. 12(5). 723–727. 55 indexed citations

Pannecouque, Christophe, Wim Pluymers, Bénédicte Van Maele, et al.. (2002). New Class of HIV Integrase Inhibitors that Block Viral Replication in Cell Culture. Current Biology. 12(14). 1169–1177. 82 indexed citations

Moukha‐Chafiq, Omar, Hassan B. Lazrek, Christophe Pannecouque, et al.. (2001). SYNTHESIS AND BIOLOGICAL ACTIVITY OF 4-SUBSTITUTED 1-[1-(2-HYDROXYETHOXY)- METHYL-1,2,3-TRIAZOL-(4 & 5)-YLMETHYL]-1H-PYRAZOLO[3,4-d]PYRIMIDINES. Nucleosides Nucleotides & Nucleic Acids. 20(10-11). 1797–1810. 18 indexed citations

10.

Asres, Kaleab, Franz Bučar, Theodor Kartnig, et al.. (2001). Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants. Phytotherapy Research. 15(1). 62–69. 124 indexed citations

11.

Martı́nez, Ana, Carmen Gil, Ana Castro, et al.. (2001). Anti-HIV-1 Activity of Benzothiadiazine Dioxide. Antiviral chemistry & chemotherapy. 12(6). 347–351. 4 indexed citations

12.

Laethem, Kristel Van, Jean‐Claude Schmit, Heidi Pelemans, et al.. (2000). Presence of 2' ,5'-Bis- O -( tert -butyldimethylsilyl)-3-spiro-5"(4"-amino-1",2"-oxathiole-2",2"-dioxide) (TSAO)-Resistant Virus Strains in TSAO-Inexperienced HIV Patients. AIDS Research and Human Retroviruses. 16(9). 825–833. 3 indexed citations

13.

Kavimani, S, et al.. (2000). Studies on anti-HIV activity of Indigofera tinctoria. Lirias (KU Leuven). 43(1). 5–7. 5 indexed citations

14.

Clercq, Erik De, Christophe Pannecouque, Myriam Witvrouw, et al.. (2000). Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates. Bioorganic & Medicinal Chemistry Letters. 10(18). 2149–2152. 4 indexed citations

15.

Cabrera, Cecilia, Myriam Witvrouw, Arantxa Gutiérrez, et al.. (1999). Resistance of the Human Immunodeficiency Virus to the Inhibitory Action of Negatively Charged Albumins on Virus Binding to CD4. AIDS Research and Human Retroviruses. 15(17). 1535–1543. 16 indexed citations

16.

Schmit, Jean-Claude, Kristel Van Laethem, Lı́dia Ruiz, et al.. (1998). Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries. AIDS. 12(15). 2007–2015. 76 indexed citations

17.

Clercq, Erik De, et al.. (1998). Anti-HIV Activity Of Some Mannich Bases Of Isatin Derivatives. Indian Journal of Pharmaceutical Sciences. 60(4). 207–212. 37 indexed citations

18.

Balzarini, Jan, J. Kruining, Christophe Pannecouque, et al.. (1997). Conversion of 2′,3′‐dideoxyadenosine (ddA) and 2′,3′‐didehydro‐2′,3′‐dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus. FEBS Letters. 410(2-3). 324–328. 53 indexed citations

19.

Balzarini, Jan, Stefano Aquaro, Carlo Federico Perno, et al.. (1996). Activity of the (R)-Enantiomers of 9-(2-Phosphonylmethoxypropyl)-Adenine and 9-(2-Phosphonylmethoxypropyl)-2,6-diaminopurine against Human Immunodeficiency Virus in Different Human Cell Systems. Biochemical and Biophysical Research Communications. 219(2). 337–341. 77 indexed citations

20.

Witvrouw, Myriam, Dominique Schols, Graciela Andreï, et al.. (1991). Antiviral Activity of low-MW Dextran Sulphate (Derived from dextran MW 1000) Compared to Dextran Sulphate Samples of Higher MW. Antiviral chemistry & chemotherapy. 2(3). 171–179. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact